Huma Qamar - Apr 16, 2024 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Role
Chief Medical Officer
Signature
/s/ Huma Qamar
Stock symbol
OCGN
Transactions as of
Apr 16, 2024
Transactions value $
$0
Form type
4
Date filed
4/17/2024, 05:41 PM
Previous filing
Mar 20, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCGN Option (Right to Buy) Award $0 +308K $0.00 308K Apr 16, 2024 Common Stock 308K $1.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests annually in equal installments over three years commencing on April 16, 2025, subject to continued service with the Issuer on the applicable vesting dates.